From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.

It can be used treat essential tremor, Parkinson’s disease, epilepsy, and neuropathic pain through sound waves ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

The Oklahoma Medical Research Foundation has received a $3 million grant to study Parkinson's disease, potentially leading to ...

While there is no cure for Parkinson’s disease, an upcoming experiment offers hope to the more than 10 million people living with the disorder that a breakthrough may be on the horizon.

Controversial Danish filmmaker Lars von Trier has been admitted to a care centre for treatment for Parkinson's disease, as ...

A woman who is at least the fourth generation of her family to suffer a "cruel" brain disorder, which leaves people trapped ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Lars von Trier has been admitted to a care centre where he will receive treatment for Parkinson’s disease. The Danish filmmaker, 68, is known for his dark and provocative films including Dancer in the ...